If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGPE Regulatory News (GPE)

Share Price Information for GPE (GPE)

Share Price is delayed by 15 minutes
Get Live Data
332.00    -2.80 (-0.84%)
Bid:
331.60
Ask:
332.00
Spread: 0.40 (0.121%)
Market Cap: £1.34b
GPE Live PriceLast checked at - London Stock Exchange

Intraday GPE Share Chart

Director/PDMR Shareholding

15 Jun 2023 09:18

RNS Number : 8469C
Great Portland Estates PLC
15 June 2023
 

14 June 2023

 

Notification of transaction by a Person Closely Associated (PCA) with a Person Discharging Managerial Responsibilities (PDMR)

 

Great Portland Estates plc (the Company) has been notified that, on 14 June 2023, Elizabeth Ann Nicholson, a person closely associated with Dan Nicholson, Executive Director, purchased ordinary shares of 155/19 pence in the Company as set out below:

 

Name

Number of shares purchased

Purchase price per ordinary share

Date of purchase

Elizabeth Ann Nicholson, PCA to Dan Nicholson, Executive Director

6,376

468.00p

14 June 2023

 

The Notification of Dealing Form can be found below. This announcement is made in accordance with Article 19 of the Market Abuse Regulation (EU) 596/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018.

 

 

1.

Details of PDMR/person closely associated with them ("PCA")

a)

Name

Elizabeth Ann Nicholson

2.

Reason for the notification

a)

Position/status

PCA to a PDMR (Dan Nicholson, Executive Director)

b)

Initial notification/amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, action platform, auctioneer or auction monitor

a)

Name

Great Portland Estates plc

 

b)

Legal Entity Identifier

213800JMEDD2Q4N1MC42

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares of 155/19 p

ISIN: GB00BF5H9P87

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price

Volume(s)

468.00p

6,376

d)

Aggregated information

- Aggregated volume

- Aggregated price

- Aggregated total

 

Aggregated volume:

Aggregated price: 468.00p

Aggregated total: £29,839.68

e)

Date of transaction

14 June 2023

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

 

Contact:

Great Portland Estates plcKay Fraser

Deputy Company Secretary

020 7647 3000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGIGDLUBBDGXU
Date   Source Headline
2nd Feb 20262:14 pmRNSDirector/PDMR Shareholding
2nd Feb 202612:34 pmRNSHolding(s) in Company
2nd Feb 20269:30 amRNSGPE appoints Non-Executive Director
29th Jan 20264:48 pmRNSHolding(s) in Company
29th Jan 202610:09 amRNSHolding(s) in Company
29th Jan 20267:00 amRNSGPE customer Vanta expands its Fitzrovia footprint
19th Jan 20264:47 pmRNSHolding(s) in Company
19th Jan 20267:00 amRNSAppointment of new Chief Financial Officer
15th Jan 202610:07 amRNSHolding(s) in Company
15th Jan 20267:00 amRNSQ3 leasing update
13th Jan 20269:28 amRNSHolding(s) in Company
7th Jan 20267:00 amRNSGPE acquires 10 South Crescent, WC1 for £51m
6th Jan 20264:28 pmRNSHolding(s) in Company
2nd Jan 20262:24 pmRNSDirector/PDMR Shareholding
15th Dec 20253:20 pmRNSHolding(s) in Company
2nd Dec 202510:17 amRNSDirector/PDMR Shareholding
24th Nov 20255:12 pmRNSHolding(s) in Company
20th Nov 202511:48 amRNSDirector/PDMR Shareholding
18th Nov 20257:00 amRNSDelivering our growth strategy
17th Nov 20254:23 pmRNSHolding(s) in Company
14th Nov 20257:00 amRNSHolding(s) in Company
10th Nov 20257:00 amRNSGPE gets planning approval for Whittington House
7th Nov 20251:34 pmRNSHolding(s) in Company
4th Nov 20257:00 amRNSSustainable Bond Allocation & Impact Report
3rd Nov 20253:01 pmRNSDirector/PDMR Shareholding
30th Oct 20255:28 pmRNSHolding(s) in Company
27th Oct 20257:00 amRNSGPE completes sale of 1 Newman Street, W1
23rd Oct 20259:03 amRNSHolding(s) in Company
23rd Oct 20257:00 amRNSGPE signs new £525 million ESG-linked RCF
22nd Oct 20257:00 amRNSHolding(s) in Company
20th Oct 20255:14 pmRNSHolding(s) in Company
17th Oct 202510:17 amRNSHolding(s) in Company
15th Oct 20257:00 amRNSGPE secures planning permission at St Thomas Yard
14th Oct 20253:05 pmRNSHolding(s) in Company
7th Oct 20257:00 amRNSWhistleblower review finds no unlawful conduct
7th Oct 20257:00 amRNSQ2 business update – strong leasing continues
2nd Oct 202510:11 amRNSHolding(s) in Company
1st Oct 20253:59 pmRNSDirector/PDMR Shareholding
29th Sep 20255:45 pmRNSHolding(s) in Company
29th Sep 20259:59 amRNSHolding(s) in Company
29th Sep 20257:00 amRNSGPE secures planning for Fully Managed scheme
25th Sep 20257:00 amRNSDirectorate Change
18th Sep 202510:06 amRNSHolding(s) in Company
18th Sep 20257:00 amRNSMoody’s reconfirms GPE’s Baa2 credit rating
17th Sep 20256:27 pmRNSHolding(s) in Company
17th Sep 20255:41 pmRNSHolding(s) in Company
15th Sep 20255:20 pmRNSHolding(s) in Company
9th Sep 20257:00 amRNSGPE expands AI customer base
1st Sep 202512:48 pmRNSDirector/PDMR Shareholding
1st Sep 20257:00 amRNSGPE grows its Fully Managed West End cluster

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.